Physicians warned about counterfeit medical devices

Physicians warned about counterfeit medical devices
Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in Surgery and Medicine.

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in Surgery and Medicine.

Brian S. Biesman, M.D., from the Nashville Center for Laser and Facial Surgery in Tennessee, and Neelam Patel, from the Vanderbilt University School of Medicine in Nashville, discuss the prevalence and dangers of counterfeit medical devices, many of which target legitimate devices manufactured by Zeitiq and Ulthera.

The researchers note that both companies' devices are protected by patents and have integrated safety features. However, the counterfeit devices are not certified as safe, reliable, or reproducible, and numerous injuries have been documented with their use. There may be economic incentives for purchasing counterfeit devices, but these are outweighed by the risks and liabilities associated with using counterfeit technology. Medical malpractice insurance carriers may not provide coverage for litigation arising from use of non-U.S. Food and Drug Administration-approved devices. There are currently 29 imitations of the Zeltiq device and at least five counterfeit Ulthera devices. Despite being unregulated and unapproved, these can be purchased via the Internet and some are displayed at legitimate trade shows.

"Physicians should be aware of the existence and prevalence of counterfeit and need to understand that use of these devices in the United States can lead to severe economic, civil, and criminal penalties," the authors write.

One author disclosed financial ties to Zeltiq and Ulthera.

More information: Full Text

add to favorites email to friend print save as pdf

Related Stories

FDA warns doctors of counterfeit Botox

Dec 24, 2012

Federal regulators have warned more than 350 medical practices that Botox they may have received from a Canadian supplier is unapproved and could be counterfeit or unsafe.

Counterfeit toothpaste is discovered

Jun 14, 2007

The U.S. Food and Drug Administration said a counterfeit toothpaste falsely packaged as "Colgate" has been found in four states.

FDA: Purveyors of phony botox targeting U.S. practices

Apr 29, 2013

(HealthDay)—Medical practices that purchase Botox may unwittingly be purchasing a fraudulent product not approved by the U.S. Food and Drug Administration for sale in the United States, according to an ...

Fake Avastin contained several chemicals, no drug

Feb 28, 2012

(AP) -- Counterfeit versions of the popular cancer drug Avastin obtained by European regulators contain a variety of chemicals, but not the active ingredient found in the genuine drug, according to drugmaker Roche.

Recommended for you

Merck completes sale of consumer unit to Bayer

7 hours ago

Drugmaker Merck said Wednesday that it completed the sale of its consumer care business, which makes products including Claritin allergy medication and Coppertone sun-care line, to German health care company Bayer for $14.2 ...

Viagra ads target women for first time

Sep 30, 2014

The maker of the world's top-selling erectile dysfunction drug on Tuesday will begin airing the first Viagra TV commercial in America that targets the less-obvious sufferers of the sexual condition: women.

User comments